About Aristogene Biosciences
Aristogene Biosciences is a company based in Bengaluru (India) founded in 2006. The company has 10 employees. Aristogene Biosciences operates in a competitive market with competitors including KBI Biopharma, Aldevron, Eurogentec, EirGenix and Ovagen, among others.
- Headquarter Bengaluru, India
- Employees 10
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aristogene.com
- Legal Name Aristogene Biosciences Private Limited
- Date of Incorporation 17 Jan, 2006
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹5.85 Cr
FY 2025 · -7% YoY
- Net Profit₹83.7 Lakh
FY 2025 · 14% margin
- EBITDA₹1.30 Cr
FY 2025 · 22% margin
- Investors
- Employee Count10
Associated legal entities of Aristogene Biosciences
Aristogene Biosciences operates through Aristogene Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aristogene Biosciences Private Limited CIN U24231KA2006PTC038261 | Active | 17 Jan 2006 | Bangalore, Karnataka | ₹5.8 Cr | 10 | 3 | View details |
Funding Insights of Aristogene Biosciences
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Aristogene Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Aristogene Biosciences
Aristogene Biosciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include C-CAMP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bioscience research, innovation, and entrepreneurship facilitation in life sciences are conducted in India. | 2010 | ccamp.res.in | Bengaluru, India |
Investor details for Aristogene Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Aristogene Biosciences Private Limited (Aristogene Biosciences)
Aristogene Biosciences Private Limited is the primary company behind Aristogene Biosciences. The board of Aristogene Biosciences Private Limited currently have 3 directors; the longest-serving is Subhashini Chakaravarthy Rangamani, appointed in 2006. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subhashini Chakaravarthy Rangamani DIN 02055923 | Director | 17 Jan 2006 | 20 yrs 8 mo | Aristogene Biosciences Private Limited |
| Vasudha Balasundaram DIN 02179429 | Director | 17 Jan 2006 | 20 yrs 8 mo | Aristogene Biosciences Private Limited |
| Sudha Lingappa DIN 02194522 | Director | 17 Jan 2006 | 20 yrs 8 mo | Aristogene Biosciences Private Limited |
People of Aristogene Biosciences
1 people are tracked at Aristogene Biosciences (1 in leadership); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Ruskin D | Owner | Leadership |
Complete people profiles for Aristogene Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Aristogene Biosciences
Figures of Aristogene Biosciences Private Limited, the primary company behind Aristogene Biosciences, for FY 2025. Revenue was ₹5.85 Cr (-7% year on year). Net profit was ₹83.7 Lakh (14% margin). EBITDA was ₹1.30 Cr (22% margin). Revenue has grown at a compounded annual rate of +2% over three years and +13% over five years.
- ₹5.85 CrRevenue · FY 2025 · -7% YoY
- ₹83.7 LakhNet profit · 14% margin
- ₹1.30 CrEBITDA · 22% margin
- ₹41.9 LakhPaid-up capital
- 10Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aristogene Biosciences Private Limited are on its company page.
Detailed financial statements for Aristogene Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Aristogene Biosciences
2 dated milestones of Aristogene Biosciences across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Aristogene Biosciences is founded.
- Funding First funding round.
Competitors of Aristogene Biosciences
Aristogene Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Eurogentec, EirGenix and Ovagen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kbibiopharma.com | 1996 | Durham, United States | $18.29M | 1,243 | Provider of protein formulation, process & cell line development, and cGMP services | |
| aldevron.com | 1998 | Fargo, United States | – | 747 | Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications | |
| eurogentec.com | 1985 | Seraing, Belgium | – | 426 | Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec. | |
| eirgenix.com | 2012 | Taipei, Taiwan | $90.58M | – | Biologics development and manufacturing services are offered by EirGenix. | |
| ovagen.ie | 2000 | Mayo, Ireland | $25.21M | – | Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services | |
| laurus.bio | 2005 | Bengaluru, India | $18.89M | 6,094 | Precision fermentation services for biopharma and food are provided. | |
| idt-biologika.com | 1921 | Dessau Rosslau, Germany | – | – | Vaccines and biologics are developed and manufactured by IDT Biologika. | |
| omniabio.com | 2001 | Rockville, United States | $25.4M | – | Process development and manufacturing services for biologics are provided. | |
| polytherics.co.uk | 2002 | Cambridge, United Kingdom | $12.56M | – | Biomedical polymers and conjugation technologies for biopharmaceuticals are developed. |
Detailed competitors of Aristogene Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aristogene Biosciences
Websites that share an audience with Aristogene Biosciences (aristogene.com).
Websites whose visitors overlap most with Aristogene Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| epochlifescience.com | 100% | – | #3,307,933 | View details | |
| usbio.com | 100% | – | – | View details | |
| mclab.com | 81% | – | #2,661,746 | View details | |
jiangsu.zxxk.com | jiangsu.zxxk.com | 61% | – | – | – |
sunrise-sys.com | sunrise-sys.com | 61% | – | #7,857,738 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Aristogene Biosciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Aristogene Biosciences
10 companies that operate in the same segment as Aristogene Biosciences (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aristogene Biosciences
Aristogene Biosciences was founded in 2006 and raised its 1st funding round 14 years after it was founded.
Aristogene Biosciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Aristogene Biosciences has 10 employees.
The primary company behind Aristogene Biosciences, Aristogene Biosciences Private Limited, reported revenue of ₹5.85 Cr for FY 2025, down 7% year on year.
Aristogene Biosciences was founded in 2006 in Bengaluru, India, as a contract research and manufacturing organization in the biotechnology sector. Multidisciplinary biology services are provided, including the production of enzymes, antibodies, teaching kits, DNA markers, proteins, and research kits. Industrial training is offered alongside RD services such as protein purification, new product process development, and molecular diagnostics. Operations focus on supporting research and industrial needs in the region.
Aristogene Biosciences's top competitors include KBI Biopharma, Aldevron and Ovagen.
Aristogene Biosciences has 1 investor. Key investors include C-CAMP.
Aristogene Biosciences operates through Aristogene Biosciences Private Limited.
The legal entities of Aristogene Biosciences currently have 3 directors, including Subhashini Chakaravarthy Rangamani, Vasudha Balasundaram, Sudha Lingappa.